Moran ben David
Directeur/Bestuurslid bij Immunyx Pharma Ltd.
Profiel
As Chief Business Development Officer at VLX, Moran brings with her a rich interdisciplinary background and skills at the cross-section of pharma drug development, biology and business and IP law from blockbuster-drugs IP litigation, to evaluation of new technologies, biological and business opportunities as well as management of collaborations worldwide.
Prior to joining VLX, Moran was Head of Business Development at Pharma Two B in Israel and held various business, strategy, and technological leadership positions in global strategic partnership and alliance management at GlaxoSmithKline, Novartis, and Takeda in Boston.
Moran is seasoned in establishing partnerships for early stage innovative projects and clinical development.
Before joining the pharmaceutical industry, Moran was a practicing lawyer, specializing in patent litigation for pharmaceutical companies.
Moran holds a BS in Biology from Tel Aviv University, a dual degree from IDC in Finance and Law, and an MBA from Boston University.
Actieve functies van Moran ben David
Bedrijven | Functie | Begin |
---|---|---|
Immunyx Pharma Ltd.
Immunyx Pharma Ltd. Pharmaceuticals: GenericHealth Technology Immunyx Pharma Ltd. is based in New York, NY. Immunyx is pioneering new approaches to immune modulation using targeted nanoparticles to change the function of neutrophils. Immunyx Pharma Ltd. was founded by Seth Salpeter, Zvi Fridlender, and Zvika Granot. Seth Salpeter has been the CEO since incorporation. | Directeur/Bestuurslid | 01-04-2021 |
Van Leer Xenia Ventures
Van Leer Xenia Ventures Investment ManagersFinance Van Leer Xenia Ventures (Van Leer Xenia Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Jerusalem, Israel. | Corporate Officer/Principal | 01-07-2019 |
Eerdere bekende functies van Moran ben David
Bedrijven | Functie | Einde |
---|---|---|
GSK PLC | Directeur/Bestuurslid | 02-05-2017 |
NOVARTIS AG | Directeur/Bestuurslid | 02-08-2016 |
Opleiding van Moran ben David
Tel-Aviv University | Undergraduate Degree |
Questrom School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
NOVARTIS AG | Health Technology |
GSK PLC | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Van Leer Xenia Ventures
Van Leer Xenia Ventures Investment ManagersFinance Van Leer Xenia Ventures (Van Leer Xenia Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Jerusalem, Israel. | Finance |
Immunyx Pharma Ltd.
Immunyx Pharma Ltd. Pharmaceuticals: GenericHealth Technology Immunyx Pharma Ltd. is based in New York, NY. Immunyx is pioneering new approaches to immune modulation using targeted nanoparticles to change the function of neutrophils. Immunyx Pharma Ltd. was founded by Seth Salpeter, Zvi Fridlender, and Zvika Granot. Seth Salpeter has been the CEO since incorporation. | Health Technology |